Global Bioprocess Technology Market Overview:
A bioprocess is any process which uses complete living cells or their components for example bacteria, enzymes, chloroplast to obtain desired products. This process is commonly known to as Fermentation. Bioprocess technology deals with the design and development of equipment and procedures for the manufacturing of products. Meanwhile, bioprocesses uses living material, they deliver numerous benefits over conventional chemical methods of production including it typically need minor temperature, pressure, and pH; it uses renewable resources as raw materials and larger quantities can be produced with less energy consumption. Some of the key players profiled in the study are Philips Healthcare (Netherlands), Abbott Laboratories (United States), Thermo Fisher Scientific Inc. (United States), Becton, Dickinson and Company (United States), GE Healthcare (United States), Merck Millipore (Germany), Danaher Corporation (United States), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France) and Charles River Laboratories (United States).
On the basis of geography, the market of Bioprocess Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Research Labs will boost the Bioprocess Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- High Growth in Biopharmaceutical Industry
- Increase in R&D Expenditure in Developed Countries
- Rise in Number of New Drug Launches
- Growing Demand for Vaccines
- Increasing Prevalence of HIV and Cancer
- Strict Regulatory Policies
- Potential Growth Offered by Emerging Markets
- Growing Pharmaceutical Outsourcing
- Need of High Capital Investments to Set Up New Production Facilities
- Difficulties in Reagent Development
On May 20, 2019 - Merck has announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative. It will provide vaccine process development training courses within TRANSVAC2, a collaborative infrastructure project under Horizon 2020.
Under the authority of the Food, Drug, and Cosmetic Act of 1938, the U.S. Food and Drug Administration (FDA) evaluates and regulates the safety of biotechnology-derived products in the same way that it does for conventionally manufactured products. Scientific, safety, and regulatory issues are considered prior to approval for commercial production. Once a product receives approval, enforcement of the laws and regulations at the manufacturing level is accomplished by FDA's field personnel. The individual firm's manufacturing and quality control procedures are reviewed and evaluated to determine if they are in compliance with the Current Good Manufacturing Practice regulations.
Target Audience:Academic Research Institutions, Pharmaceutical Industry, Biotechnology Industry, Bioprocess Technology Manufacturing Companies, Research Organizations and Governmental Bodies
Major Objectives Focused through this Study To define, describe, and forecast the Global Bioprocess Technology market on the basis of product [Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry and Virus Infiltration] , application [Specialty Products, Biopharmaceuticals, Environment Management and Industrial Chemicals], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Bioprocess Technology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Bioprocess Technology industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Corning, Inc. (United States) and Bio-Rad Laboratories (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Bioprocess Technology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.